Virtus ETF Advisers LLC Axsome Therapeutics, Inc. Transaction History

Virtus ETF Advisers LLC

$234 Million
Q4 2024

A detailed history of Virtus ETF Advisers LLC transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Virtus ETF Advisers LLC holds 3,705 shares of AXSM stock, worth $510,363. This represents 0.13% of its overall portfolio holdings.

Number of Shares

3,705

Previous 4,542 18.43%

Holding current value

$510,363

Previous $408,000 23.28%

% of portfolio

0.13%

Previous 0.2%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$83.08 - $100.49 $69,537 - $84,110	-837 Reduced 18.43%	3,705 $313,000
Q2 2024 Aug 14, 2024	SELL	$65.72 - $80.5 $43,243 - $52,969	-658 Reduced 12.65%	4,542 $365,000
Q1 2024 May 15, 2024	BUY	$69.39 - $97.64 $51,903 - $73,034	748 Added 16.8%	5,200 $414,000
Q4 2023 Feb 15, 2024	BUY	$57.42 - $83.61 $39,619 - $57,690	690 Added 18.34%	4,452 $354,000
Q3 2023 Nov 07, 2023	SELL	$69.25 - $82.21 $33,586 - $39,871	-485 Reduced 11.42%	3,762 $262,000
Q2 2023 Aug 14, 2023	BUY	$58.41 - $90.35 $22,604 - $34,965	387 Added 10.03%	4,247 $305,000
Q1 2023 May 15, 2023	BUY	$58.39 - $75.0 $3,795 - $4,875	65 Added 1.71%	3,860 $238,000
Q4 2022 Feb 14, 2023	SELL	$39.94 - $79.72 $264,322 - $527,586	-6,618 Reduced 63.56%	3,795 $292,000
Q3 2022 Nov 14, 2022	BUY	$36.06 - $69.85 $5,553 - $10,756	154 Added 1.5%	10,413 $465,000
Q2 2022 Aug 12, 2022	BUY	$21.74 - $46.75 $113,178 - $243,380	5,206 Added 103.03%	10,259 $393,000
Q1 2022 May 16, 2022	SELL	$23.7 - $41.39 $7,038 - $12,292	-297 Reduced 5.55%	5,053 $209,000
Q4 2021 Feb 14, 2022	BUY	$30.7 - $43.36 $67,662 - $95,565	2,204 Added 70.06%	5,350 $202,000
Q3 2021 Nov 15, 2021	SELL	$19.91 - $68.26 $3,324 - $11,399	-167 Reduced 5.04%	3,146 $104,000
Q2 2021 Aug 10, 2021	SELL	$50.63 - $73.5 $22,530 - $32,707	-445 Reduced 11.84%	3,313 $223,000
Q1 2021 May 17, 2021	BUY	$55.91 - $81.44 $3,801 - $5,537	68 Added 1.84%	3,758 $213,000
Q4 2020 Feb 12, 2021	SELL	$66.31 - $86.52 $38,393 - $50,095	-579 Reduced 13.56%	3,690 $301,000
Q3 2020 Nov 13, 2020	SELL	$68.34 - $85.84 $38,953 - $48,928	-570 Reduced 11.78%	4,269 $304,000
Q2 2020 Aug 05, 2020	SELL	$49.87 - $98.69 $142,079 - $281,167	-2,849 Reduced 37.06%	4,839 $398,000
Q1 2020 May 14, 2020	SELL	$41.2 - $101.31 $45,855 - $112,758	-1,113 Reduced 12.65%	7,688 $452,000
Q4 2019 Feb 13, 2020	SELL	$16.71 - $106.24 $38,015 - $241,696	-2,275 Reduced 20.54%	8,801 $910,000
Q3 2019 Nov 12, 2019	SELL	$20.24 - $29.16 $12,467 - $17,962	-616 Reduced 5.27%	11,076 $224,000
Q2 2019 Aug 13, 2019	BUY	$13.46 - $25.75 $157,374 - $301,069	11,692 New	11,692 $301,000

Others Institutions Holding AXSM

# of Institutions

351

Shares Held

36.3M

Call Options Held

1.77M

Put Options Held

1.16M

View Full List

About Axsome Therapeutics, Inc.

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $5.91B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

More about AXSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.

Account

Virtus ETF Advisers LLC Axsome Therapeutics, Inc. Transaction History